ARCA biopharma, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €16.30K
    Gross profit
    -€26.60K
    SG&A expenses
    €12.36M
    R&D expenses
    €38.02M
    EBITDA
    -€50.70M
    D&A
    €26.60K
    EBIT
    -€50.72M
    Interest expenses
    €0.00
    EBT
    -€43.12M
    Tax expenses
    -€21.29K
    Net income
    -€43.12M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€3.02M
    Changes in working capital
    €229.94K
    Operating cash flow
    -€41.34M
    Capex
    €40.33K
    Other investing cash flow
    €0.00
    Net investing cash flow
    €40.95M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €105.53K
    Debt repayment
    €0.00
    Other financing cash flow
    €105.53K
    Net financing cash flow
    €105.53K
    Foreign exchange effects
    €0.00
    Net change in cash
    -€280.57K
    Cash at end of period
    €56.11M
    Free cash flow
    -€41.29M

    Balance sheet

    Cash and cash equivalents
    €56.11M
    Cash and short-term investments
    €281.77M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €3.09M
    Total current assets
    €284.87M
    Property, plant & equipment
    €1.93M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €19.87M
    Total non-current assets
    €21.80M
    Total assets
    €306.66M
    Accounts payable
    €4.00M
    Short-term debt
    €566.28K
    Other current liabilities
    €5.82M
    Total current liabilities
    €10.39M
    Long-term debt
    €1.43M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €1.43M
    Total liabilities
    €11.82M
    Common stock
    €2.68M
    Retained earnings
    -€110.94M
    Other equity
    -€23.17K
    Total equity
    €294.85M
    Total liabilities and shareholders' equity
    €306.66M

    Company information

    Market capitalization
    €29.70M
    Employees
    3
    Enterprise Value
    -€47.81M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -14.6%
    ROA
    -14.1%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -139.3%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€14.37M

    Notifications